An interventional study of Product Intervention in Urinary Tract Infection, Recurrent Urinary Tract Infection and Urinary Symptoms, sponsored by Good Kitty Co. Active, not recruiting at 1 site in United States. Open to participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-11-18.
Sponsored by Good Kitty Co · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 274 studies in Urinary Tract Infections with a site in United States — 43 open to participants now, 56 under way, 2 of them phase 3. Urinary Tract Infections · United States.
Among the 274 studies in Urinary Tract Infections with a site in United States, this one is the 151st largest by enrollment of the 224 interventional ones that give a count, is one of 20 that started in 2026, is one of 94 with no phase, reaches primary completion later than 12 of the 55 other live ones, and was the 274th registered.
807 studies on the registry are indexed under Urinary Tract Infections; 133 are open to participants now.
Browse Urinary Tract Infections studies →43 of the 274 studies in Urinary Tract Infections with a site in United States are open now. Recruiting first, the newest first:
GlaxoSmithKline · Sites in United States
Ages 15–50 · Women only
University of Miami · Sites in United States
Ages 18+ · Women only
GlaxoSmithKline · Sites in United States
Ages 18–50 · Women only · Healthy volunteers
Megan Bradley · Sites in United States
Ages 65+ · Women only
Baylor College of Medicine · Sites in United States
Ages 0 mo–5 mo · Men only
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 83 Urinary Tract Infections studies recruiting now, 50 (60%) set no upper age limit and 23 (28%) stop at 75 or younger; 16 take children under 18; 15 take healthy volunteers.
This study: 18 Years to 45 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
274 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 27 · Phase 2 41 · Phase 3 33 · Phase 4 39
First in 1988; this study’s year is marked. 20 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 44 is below the median of 132 across 563 interventional studies indexed under Urinary Tract Infections.
Median enrollment 100 across the 224 interventional studies, 229 across the 50 observational. Of the 190 that completed or were terminated, 89 (47%) have results posted.
This tab as a report to print or save as PDF → With an account.
73 of 274 have an industry lead sponsor. The 10 most frequent:
This is the only study on the registry with Good Kitty Co as lead sponsor.
Good Kitty Co has 1 study filed under Urinary Tract Infections — fewer than ten, so there is no comparison to draw.
26 of the studies in Urinary Tract Infections with a site in United States that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07686055Phase 3Megan BradleyPrecision Management of Urinary Tract Symptoms in Older Women | 2027-02-01 |
| NCT07947108Good Kitty CoA Clinical Trial to Evaluate the Effects of a Supplement on Urinary Symptoms | 2026-12 |
| NCT06976125University Hospitals Cleveland Medical CenterApplication of a Prediction Model for Directing Antibiotic Use in the Treatment of Urinary Tract Infection in an Ambulatory Setting | 2026-12-01 |
| NCT07453693Bonafide HealthAn Efficacy Study of a Dietary Supplement Drink Mix for Urinary Health Improvement | 2026-12-15 |
| NCT07542834Ohio UniversityUsing Virtual Reality to Improve Medical Training | 2026-12-31 |
Add all 26 to your calendar (.ics) → With an account.
Among the 274 studies in Urinary Tract Infections with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study will evaluate the effects of the UTI Biome Shield capsule on urinary symptoms in sexually active women aged 18-45 who experience recurrent symptoms associated with urinary tract infections (UTIs). The trial is a single-arm, unblinded, virtual study conducted over six months, in which all 44 enrolled participants will use the test product daily.
Participants will complete questionnaires at Baseline and at the end of Months 1 through 6. The primary objective is to examine the product's effects on urinary symptoms, while secondary objectives assess participants' perceptions of the product's effects, including reduced recurrence of UTI-associated symptoms in sexually active women and reduced recurrence of symptoms after sex.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraception
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Dietary Supplement: Product Intervention
All participants will be using the test product as directed. Participants who are sexually active in the morning will take the UTI Biome Shield capsule once daily in the afternoon after food. Participants who are sexually active in the evening will take the UTI Biome Shield capsule once daily in the morning after food. Participants will also take three capsules before sex.
Change in Urinary Symptoms
Changes in urinary symptoms assessed via self-reported questionnaire
Time frame: Baseline, Month 1, Month 2, Month 3, Month 4, Month 5, and Month 6
Recurrence of Symptoms Associated with Urinary Tract Infections in Sexually Active Women
Participants' self-reported perceptions of recurrence of UTI-associated symptoms (frequent and urgent urination, burning sensation during urination, cloudy urine) in sexually active women, assessed via questionnaire
Time frame: Baseline, Month 1, Month 2, Month 3, Month 4, Month 5, and Month 6
Recurrence of Symptoms Associated with Urinary Tract Infections After Sex
Participants' self-reported perceptions of recurrence of UTI-associated symptoms after sexual activity, assessed via questionnaire
Time frame: Baseline, Month 1, Month 2, Month 3, Month 4, Month 5, and Month 6
Started Apr 2026 (actual). Primary completion is estimated for Dec 2026, 8 months after the start.
Of 154 interventional studies with no phase under Urinary Tract Infections, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 37. This study's planned 8 months is below that.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is active, not recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.